BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15357840)

  • 1. Expression of gp100 and CDK2 in melanoma cells is not co-regulated by a shared promoter region.
    Stennett LS; Riker AI; Kroll TM; ChaMberlin J; Miki T; Nickoloff BJ; Le Poole IC
    Pigment Cell Res; 2004 Oct; 17(5):525-32. PubMed ID: 15357840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF.
    Du J; Widlund HR; Horstmann MA; Ramaswamy S; Ross K; Huber WE; Nishimura EK; Golub TR; Fisher DE
    Cancer Cell; 2004 Dec; 6(6):565-76. PubMed ID: 15607961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.
    Du J; Miller AJ; Widlund HR; Horstmann MA; Ramaswamy S; Fisher DE
    Am J Pathol; 2003 Jul; 163(1):333-43. PubMed ID: 12819038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of microphthalmia transcription factor in regulation of melanocyte differentiation marker TRP-1.
    Fang D; Setaluri V
    Biochem Biophys Res Commun; 1999 Mar; 256(3):657-63. PubMed ID: 10080955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence of a role for activating CDK2 mutations in melanoma.
    Walker G; Hayward N
    Melanoma Res; 2001 Aug; 11(4):343-8. PubMed ID: 11479422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma.
    Busam KJ; Iversen K; Coplan KC; Jungbluth AA
    Am J Surg Pathol; 2001 Feb; 25(2):197-204. PubMed ID: 11176068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In B16 melanoma cells, the inhibition of melanogenesis by TPA results from PKC activation and diminution of microphthalmia binding to the M-box of the tyrosinase promoter.
    Bertolotto C; Bille K; Ortonne JP; Ballotti R
    Oncogene; 1998 Apr; 16(13):1665-70. PubMed ID: 9582014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of tyrosinase-related protein-2 (TYRP2) in human melanocytes: relationship to growth and morphology.
    Fang D; Kute T; Setaluri V
    Pigment Cell Res; 2001 Apr; 14(2):132-9. PubMed ID: 11310793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines.
    Hertzman Johansson C; Azimi A; Frostvik Stolt M; Shojaee S; Wiberg H; Grafström E; Hansson J; Egyházi Brage S
    Melanoma Res; 2013 Oct; 23(5):360-5. PubMed ID: 23921446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Pmel17/gp100 expression in primary human tissue specimens: implications for melanoma immuno- and gene-therapy.
    Wagner SN; Wagner C; Schultewolter T; Goos M
    Cancer Immunol Immunother; 1997 Jun; 44(4):239-47. PubMed ID: 9222283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest.
    Strobeck MW; Fribourg AF; Puga A; Knudsen ES
    Oncogene; 2000 Apr; 19(15):1857-67. PubMed ID: 10773875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma.
    Miller AJ; Du J; Rowan S; Hershey CL; Widlund HR; Fisher DE
    Cancer Res; 2004 Jan; 64(2):509-16. PubMed ID: 14744763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human melastatin 1 (TRPM1) is regulated by MITF and produces multiple polypeptide isoforms in melanocytes and melanoma.
    Zhiqi S; Soltani MH; Bhat KM; Sangha N; Fang D; Hunter JJ; Setaluri V
    Melanoma Res; 2004 Dec; 14(6):509-16. PubMed ID: 15577322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracutaneous genetic immunization with autologous melanoma-associated antigen Pmel17/gp100 induces T cell-mediated tumor protection in vivo.
    Wagner SN; Wagner C; Lührs P; Weimann TK; Kutil R; Goos M; Stingl G; Schneeberger A
    J Invest Dermatol; 2000 Dec; 115(6):1082-7. PubMed ID: 11121145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative antiproliferative signaling by aspirin and indole-3-carbinol targets microphthalmia-associated transcription factor gene expression and promoter activity in human melanoma cells.
    Poindexter KM; Matthew S; Aronchik I; Firestone GL
    Cell Biol Toxicol; 2016 Apr; 32(2):103-19. PubMed ID: 27055402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human thyroxine-binding globulin gene: complete sequence and transcriptional regulation.
    Hayashi Y; Mori Y; Janssen OE; Sunthornthepvarakul T; Weiss RE; Takeda K; Weinberg M; Seo H; Bell GI; Refetoff S
    Mol Endocrinol; 1993 Aug; 7(8):1049-60. PubMed ID: 8232304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas.
    Konduri SD; Osman FA; Rao CN; Srinivas H; Yanamandra N; Tasiou A; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Kouraklis G; Rao JS
    Oncogene; 2002 Jan; 21(6):921-8. PubMed ID: 11840337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.
    Buscà R; Berra E; Gaggioli C; Khaled M; Bille K; Marchetti B; Thyss R; Fitsialos G; Larribère L; Bertolotto C; Virolle T; Barbry P; Pouysségur J; Ponzio G; Ballotti R
    J Cell Biol; 2005 Jul; 170(1):49-59. PubMed ID: 15983061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiles of melanogenesis-related genes and proteins in acquired melanocytic nevus.
    Hashimoto Y; Ito Y; Kato T; Motokawa T; Katagiri T; Itoh M
    J Cutan Pathol; 2006 Mar; 33(3):207-15. PubMed ID: 16466507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.